A uniquely prevalent nonnucleoside reverse transcriptase inhibitor resistance mutation in Russian subtype A HIV-1 viruses
Optimizing parallel induction of HIV type 1-specific antibody and T-cell responses by multicomponent subunit vaccines
Relationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohort
Genetic variation in Trex1 affects HIV-1 disease progression
Identification of antibody glycosylation structures that predict monoclonal antibody Fc-effector function
Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapy
Myocardial and microvascular inflammation/infection in patients with HIV-associated pulmonary artery hypertension
Antiretroviral drugs for prevention of mother-to-child transmission
Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease
Effect of CD4+ cell count and viral suppression on risk of ischemic stroke in HIV infection
Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial
Temporal trends in mortality among people who use drugs compared with the general Dutch population differ by hepatitis C virus and HIV infection status
Long-term cumulative detection of human papillomavirus among HIV seropositive women
Complications of cesarean deliveries among HIV-infected women in the United States
Selective acquisition of G190S in HIV-1 subtype A from Russia leading to efavirenz and nevirapine treatment failure
Antiretroviral nanoparticles
Long-acting three-drug combination anti-HIV nanoparticles enhance drug exposure in primate plasma and cells within lymph nodes and blood
Effects of atorvastatin and pravastatin on immune activation and T-cell function in antiretroviral therapy-suppressed HIV-1-infected patients
Pulmonary complications associated with pegylated interferon and ribavirin in HIV/hepatitis C virus coinfected patients
Minor viral population with drug-resistant mutation and risk of persistent low-level viremia or ‘blips’ in HIV-1 subtype C
A case of iatrogenic adrenal suppression after co-administration of cobicistat and fluticasone nasal drops
Futility of CD4+ monitoring in HIV-1 patients with CD4+ cell count above 350 cells/μl on suppressive antiretroviral therapy
Maternal HIV disclosure to young HIV-uninfected children